https://ipharmag.com/article/telix-itm-acquisition-radiopharmaceutical-2-35-billion iPharmag en 2026-09-21T15:11:24+00:00 Telix Bets Up to $2.35B on ITM to Build a Radiopharmaceutical Powerhouse https://ipharmag.com/article/maxialtrode-needle-thin-brain-implant-three-functions iPharmag en 2026-09-21T15:11:24+00:00 A Hair-Thin Brain Implant Can Record, Medicate and Stimulate All at Once https://ipharmag.com/article/kratom-7-oh-withdrawal-addiction-clinics-surge iPharmag en 2026-09-21T15:11:24+00:00 Addiction Clinics Report a Surge in Withdrawal From Potent Kratom Products https://ipharmag.com/article/fda-nonclinical-tests-animal-testing-alternatives-rule iPharmag en 2026-09-21T15:11:24+00:00 FDA Rewrites Its Rules to Make Room for Alternatives to Animal Testing https://ipharmag.com/article/calcium-vitamin-d-supplements-little-bone-benefit-review iPharmag en 2026-09-21T15:11:24+00:00 Millions Take Calcium and Vitamin D for Their Bones. A Big Review Finds Little Benefit https://ipharmag.com/article/walton-100m-pledge-maternal-mortality-healthy-moms-healthy-babies-2 iPharmag en 2026-09-21T03:22:22+00:00 $100 Million and Five Years: A Bipartisan Bet on Halving U.S. Maternal Deaths https://ipharmag.com/article/uroactive-remote-controlled-urinary-sphincter-men iPharmag en 2026-09-20T17:37:38+00:00 A Remote-Controlled Implant Could Rethink Incontinence Treatment for Men https://ipharmag.com/article/mal-blood-group-anwj-antigen-discovery iPharmag en 2026-09-20T17:37:38+00:00 Scientists Crack a 50-Year Mystery and Name a New Human Blood Group https://ipharmag.com/article/fda-psychedelics-regulation-access-balance iPharmag en 2026-09-20T17:37:38+00:00 As Psychedelic Medicines Near Approval, the FDA Weighs Safety Against Access https://ipharmag.com/article/clinical-trial-discovery-gap-patient-matching iPharmag en 2026-09-20T17:37:38+00:00 The Trials Were Always There. Patients Just Couldn’t Find Them https://ipharmag.com/article/bundibugyo-virus-ebola-relative-outbreak-drc iPharmag en 2026-09-20T17:37:38+00:00 A Deadly Ebola Relative Is Surging After Years in the Shadows https://ipharmag.com/article/time-restricted-eating-huntingtons-disease-markers iPharmag en 2026-09-20T04:24:12+00:00 Could a Timed Eating Window Slow Huntington’s? A Small Study Offers a Hint https://ipharmag.com/article/shorter-antibiotics-orthopedic-infection-salatio iPharmag en 2026-09-20T04:24:12+00:00 Shorter Antibiotic Courses May Work Just as Well for Bone Infections https://ipharmag.com/article/paracervical-block-iud-insertion-pain-trial iPharmag en 2026-09-20T04:24:12+00:00 A Numbing Injection Meaningfully Eased IUD-Insertion Pain in a Rigorous Trial https://ipharmag.com/article/lilly-brenipatide-gip-glp1-addiction-psychiatric-disorders iPharmag en 2026-09-20T04:24:12+00:00 Lilly Is Testing a Cousin of Its Obesity Drug for Addiction and Depression https://ipharmag.com/article/jehovahs-witnesses-blood-derived-products-policy iPharmag en 2026-09-20T04:24:12+00:00 Jehovah’s Witnesses Ease a Decades-Old Blood Rule — but Keep the Core Ban